Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kimura, Tomonori ^a,e   Yasuda, Keiko ^a   Yamamoto, Ryohei ^a   Soga, Tomoyoshi ^b   Rakugi, Hiromi ^a   Hayashi, Terumasa ^c,d   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Department of Paediatrics   (Japan)

^d Rinku General Medical Center   (Japan)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER;

BLOOD; CAPILLARY ELECTROPHORESIS; CHEMISTRY; CHRONIC KIDNEY FAILURE; FOLLOW UP; HUMAN; ISOMERISM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; PATHOLOGY; PLASMA; PROGNOSIS; PROSPECTIVE STUDY;

AMINO ACIDS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, CAPILLARY; FOLLOW-UP STUDIES; HUMANS; ISOMERISM; KIDNEY FAILURE, CHRONIC; MASS SPECTROMETRY; METABOLOMICS; PLASMA; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84969941318     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26138     Document Type: Article

References (40)

1. Levey, A. S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72, 247-259 (2007).
2. Coresh, J., Astor, B. C., Greene, T., Eknoyan, G. & Levey, A. S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41, 1-12 (2003).
3. Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42, 1050-1065 (2003).
4. Kimura, T. et al. Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography. Nephrol Dial Transplant 26, 1838-1846 (2011).
5. Yasuda, K. et al. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease. Nephrol Dial Transplant 27, 3885-3891 (2012).
6. Obi, Y. et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol 5, 1558-1565 (2010).
7. Kimura, T. et al. Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 9, 1876-1886 (2013).
8. Namba, T. et al. Autophagic Clearance of Mitochondria in the Kidney Copes with Metabolic Acidosis. J Am Soc Nephrol 25, 2254-2266 (2014).
9. Toyohara, T. et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33, 944-952 (2010).
10. Shah, V. O. et al. Plasma metabolomic profiles in different stages of CKD. Clin J Am Soc Nephrol 8, 363-370 (2013).
11. Hirayama, A. et al. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem 404, 3101-3109 (2012).
12. Sharma, K. et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 24, 1901-1912 (2013).
13. Nkuipou-Kenfack, E. et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One 9, e96955 (2014).
14. Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21, 1041-1051 (2010).
15. Rhee, E. P. et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol 24, 1330-1338 (2013).
16. Yu, B. et al. Serum metabolomic profiling and incident CKD among African Americans. Clin J Am Soc Nephrol 9, 1410-1417 (2014).
17. Goek, O. N. et al. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 60, 197-206 (2012).
18. Goek, O. N. et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transplant 28, 2131-2138 (2013).
19. Niewczas, M. A. et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 85, 1214-1224 (2014).
20. Breit, M. & Weinberger, K. M. Metabolic biomarkers for chronic kidney disease. Arch Biochem Biophys 589, 62-80 (2016).
21. Soga, T. et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281, 16768-16776 (2006).
22. Hirayama, A. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69, 4918-4925 (2009).
23. Vaziri, N. D. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 21, 587-592 (2012).
24. Nangaku, M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17, 17-25 (2006).
25. Counahan, R., El-Bishti, M., Cox, B. D. & Ogg, C. S. Plasma amino acids in children and adolescents on hemodialysis. Kidney Int 10, 471-477 (1976).
26. Gerrits, G. P. et al. Disturbances of cerebral purine and pyrimidine metabolism in young children with chronic renal failure. Nephron 58, 310-314 (1991).
27. Daniels, J. C. et al. Altered nucleic acid synthesis patterns in lymphocytes from patients with chronic uremia. Am J Med Sci 259, 214-227 (1970).
28. Kikuchi, T. et al. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. Clin Chem 27, 1899-1902 (1981).
29. Simenhoff, M. L., Burke, J. F., Saukkonen, J. J., Ordinario, A. T. & Doty, R. Biochemical profile or uremic breath. N Engl J Med 297, 132-135 (1977).
30. Boudonck, K. J. et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 37, 280-292 (2009).
31. Asatoor, A. M. & Armstrong, M. D. 3-methylhistidine, a component of actin. Biochem Biophys Res Commun 26, 168-174 (1967).
32. Kopple, J. D. McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65, 1544-1557 (1997).
33. Humphreys, B. D. et al. Acetaminophen-Induced Anion Gap Metabolic Acidosis and 5-Oxoprolinuria (Pyroglutamic Aciduria) Acquired in Hospital. American Journal of Kidney Diseases 46, 143-146 (2005).
34. Eloot, S. et al. Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol 6, 1266-1273 (2011).
35. Aronov, P. A. et al. Colonic contribution to uremic solutes. J Am Soc Nephrol 22, 1769-1776 (2011).
36. Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53, 982-992 (2009).
37. Soga, T. et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2, 488-494 (2003).
38. Hirayama, A., Igarashi, K., Tomita, M. & Soga, T. Development of quantitative method for determination of gamma-glutamyl peptides by capillary electrophoresis tandem mass spectrometry: an efficient approach avoiding matrix effect. J Chromatogr A 1369, 161-169 (2014).
39. Soga, T. et al. Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem 81, 6165-6174 (2009).
40. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria, 2005. http://www.R-project.org (12 Dec 2012, date last accessed).